BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32502542)

  • 1. The immune system and COVID-19: Friend or foe?
    Yazdanpanah F; Hamblin MR; Rezaei N
    Life Sci; 2020 Sep; 256():117900. PubMed ID: 32502542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
    Loganathan S; Kuppusamy M; Wankhar W; Gurugubelli KR; Mahadevappa VH; Lepcha L; Choudhary AK
    Respir Physiol Neurobiol; 2021 Jan; 283():103548. PubMed ID: 32956843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Insights into Immune Responses during COVID-19.
    St John AL; Rathore APS
    J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-A Tough Opponent for the Immune System.
    Nasab MG; Saghazadeh A; Rezaei N
    Arch Med Res; 2020 Aug; 51(6):589-592. PubMed ID: 32532524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 Novel Coronavirus Pandemic: What Do We Know?
    Margallo LN; Diaz M; Lim PP
    S D Med; 2020 Jun; 73(6):262-264. PubMed ID: 32580258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2: a storm is raging.
    Pedersen SF; Ho YC
    J Clin Invest; 2020 May; 130(5):2202-2205. PubMed ID: 32217834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: In the Eye of the Cytokine Storm.
    de la Rica R; Borges M; Gonzalez-Freire M
    Front Immunol; 2020; 11():558898. PubMed ID: 33072097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanisms responsible for acute coronary events in COVID-19.
    Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
    Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
    Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
    Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.
    Tamimi F; Abusamak M; Akkanti B; Chen Z; Yoo SH; Karmouty-Quintana H
    Br J Pharmacol; 2020 Nov; 177(21):4845-4850. PubMed ID: 32442317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings.
    Öztürk R; Taşova Y; Ayaz A
    Turk J Med Sci; 2020 Apr; 50(SI-1):638-657. PubMed ID: 32512673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
    Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
    Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
    Bouadma L; Wiedemann A; Patrier J; Surénaud M; Wicky PH; Foucat E; Diehl JL; Hejblum BP; Sinnah F; de Montmollin E; Lacabaratz C; Thiébaut R; Timsit JF; Lévy Y
    J Clin Immunol; 2020 Nov; 40(8):1082-1092. PubMed ID: 32829467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIS-C After ARDS Associated With SARS-CoV-2.
    Clouser K; Baer A; Bhavsar S; Gadhavi J; Li S; Schnall J; Weiss JE
    Pediatr Infect Dis J; 2020 Nov; 39(11):e363-e365. PubMed ID: 32898090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Management of Cytokine Storm in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.